Journal of Substance Abuse Treatment
Volume 14, Issue 6 , Pages 535-542 , November 1997

Hydromorphone polymer implant A potential alternative to methadone maintenance

  • Deborah J. Rhodes, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to S.A. Grossman, The Johns Hopkins Oncology Center, 600 N. Wolfe St., Baltimore, MD 21287-8939.
    • ,
  • Stuart A. Grossman, MD

Received 26 August 1996 ,Revised 21 January 1997 ,Accepted 31 March 1997.

References 

  1. Alcohol, Drug Abuse, and Mental Health Administration . Drug abuse treatment: An economical approach to addressing the drug problem in America. In: DHHS Publication No. ADM 91-1934. Washington, DC: U.S. Government Printing Office; 1991;
  2. Ball JC, Lange WR, Myers DP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior. 1988;29:214–226
  3. Ball JC, Nurco DN, Clayton RR, Lerner M, Hagan TA, Groves GA. Etiology, epidemiology, and natural history of heroin addiction: A social science approach. In: Problems of drug dependence, 1994.  Harris LS editors. National Institute on Drug Abuse Research Monograph Series. 152:Washington, DC: U.S. Government Printing Office; 1995;p. 74–78 (DHHS Publication No. ADM 95-3882
  4. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag; 1991;
  5. In: Rx: 3x/week LAAM alternative to methadone.  Blaine JD,  Renault PF editor. National Institute on Drug Abuse Research Monograph Series. 8:Washington, DC: U.S. Government Printing Office; 1976; (DHHS Publication No. ADM 78-347)
  6. Centers for Disease Control and Prevention . HIV/AIDS Surveillance Report. 1994;6(1):
  7. Des Jarlais DC, Joseph H, Dole VP, Nyswander ME. Medical maintenance feasibility study. In: Progress in the development of cost-effective treatment for drug abusers.  Ashery RS editors. National Institute on Drug Abuse Research Monograph. 58:Washington, DC: U.S. Governent Printing Office; 1985;p. 101–110 (DHHS Publication No. ADM 85-1401)
  8. Dole VP, Joseph H. Long-term outcome of patients treated with methadone maintenance. Annals New York Academy of Sciences. 1978;311:181–189
  9. In:  Fulco CE,  Liverman CT,  Earley LE editor. Development of medications for the treatment of opiate and cocaine addictions: Issues for the government and private sector. Washington, DC: National Academy Press; 1994;
  10. Kreek MJ. Health consequences associated with the use of methadone. In: Research on the treatment of narcotic addiction: State of the art.  Cooper JR,  Altman F,  Brown BS,  Czechowicz D editor. National Institute on Drug Abuse Research Monograph Series. Washington, DC: U.S. Government Printing Office; 1983;p. 456–481 (DHHS Publication No. ADM 83-1281)
  11. Kreek MJ. Using methadone effectively: Achieving goals by application of laboratory, clinical, and evaluation research and by development of innovative programs. In: Improving drug abuse treatment, 1991.  Pickens RW,  Leukefeld CG,  Schuster CR editor. National Institute on Drug Abuse Research Monograph Series. 106:Washington, DC: U.S. Government Printing Office; 1991;p. 245–266 (DHHS Publication No. ADM 91-1754)
  12. Kreek MJ, Wardlaw SL, Hartman N, Raghunath J, Friedman J, Schneider B, et al. Circadian rhythms and levels of B-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sciences. 1983;33(Suppl. I):409–411
  13. Lesser GJ, Grossman SA, Leong KW, Lo H, Eller S. In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Pain. 1996;65:265–272
  14. McCaul ME, Bigelow GE, Stitzer ML, Liebson I. Short-term effects of oral methadone in methadone maintenance subjects. Clinical Pharmacologal and Therapeutics. 1982;31:753–761
  15. McLellan AT, Amdt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959
  16. Newman RG. Methadone treatment: Defining and evaluating success. New England Journal of Medicine. 1987;317:447–450
  17. Jovick DM, Joseph H. Medical maintenance: the treatment of opiate dependence in general medical practice. Journal of Substance Abuse Treatment. 1991;8:233–239
  18. Novick DM, Joseph H, Croxson TS, Salsitz EA, Wang G, Richman BL, et al. Absence of antibody to human immunodeficiency virus in longterm, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine. 1990;150:97–99
  19. Novick DM, Ochshorn M, Ghali V, Croxson TS, Mercer WD, Chiorazzi N, et al. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. The Journal of Pharmcology and Experimental Therapeutics. 1989;250:606–610
  20. Novick DM, Pascarelli EF, Joseph H, Salsitz EA, Richman BL, Des Jarlais DC, et al. Methadone maintenance patients in general medical practice: A preliminary report. JAMA. 1988;259:3299–3302
  21. Novick DM, Richman BL, Friedman JM, Friedman JE, Fried C, Wilson JP, et al. The medical status of methadone maintenance patients in treatment for l1–18 years. Drug and Alcohol Dependence. 1993;33:235–245
  22. Pickens RW, Fletcher BW. Overview of treatment issues. In: Improving drug abuse treatment.  Pickens RW,  Leukefeld CG,  Schuster CR editor. National Institute on Drug Abuse Research Monograph Series. 106:Washington, DC: U.S. Government Printing Office; 1991;p. 417; DHHS Publication No. ADM 95-3883
  23. Senay EC, Barthwell AG, Marks R, Bokos P. Medical maintenance: A five year experience. In: Prolems of drug dependence, 1994.  Harris L editors. National Institute on Drug Abuse Research Monograph Series. 153:Washington, DC: U.S. Government Printing Office; 1995;p. 471; (DHHS Publication No. ADM 953883)
  24. Simpson DD. Treatment for drug abuse. Archives of General Psychiatry. 1981;38:875–880
  25. Simpson DD. National treatment system evaluation based on the Drug Abuse Reporting Program (DARP) follow up research. In: Drug abuse treatment evaluation: Strategies, progress, and prospects.  Tims FM,  Ludford JP editor. National Institute on Drug Abuse Research Monograph Series. 51:Washington, DC: U.S. Government Printing Office; 1984;p. 1–19 DHHS Publication No. ADM 84-1329
  26. Stitzer M, Bigelow G. Contingency management in a methadone maintenance program: Availability of reinforcers. The International Journal of the Addictions. 1978;13:737–746
  27. Stitzer ML, Bigelow GE, Iguchi MY. Behavioral interventions in the methadone clinic: Contingent methadone take-home incentives. In: Problems of drug dependence, 1992.  Harris L editors. National Institute on Drug Abuse Research Monograph Series. 132:Washington, DC: U.S. Government Printing Office; 1993;p. 66; DHHS Publication No. ADM 93-3505
  28. Stitzer ML, Kirby KC. Reducing illicit drug use among methadone patients. In: Improving drug abuse treatment.  Pickens RW,  Leukefeld CG,  Schuster CR editor. National Institute on Drug Abuse Research Monograph Series. 106:Washington, DC: U.S. Government Printing Office; 1991;p. 178–203 DHHS Publcation No. ADM 91-1754
  29. Tims FM, Fletcher BW, Hubbard RL. Treatment outcomes for drug abuse clients. In: Improving drug abuse treatment.  Pickens RW,  Leukefeld CG,  Schuster CR editor. National Institute on Drug Abuse Research Monograph Series. 106:Washington, DC: U.S. Government Printing Office; 1991;p. 93–113 DHHS Publication No. ADM 91-1754
  30. Vlahov D, Anthony JC, Munoz A, Margolick J, Nelson KE, Celentano DD, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. In: Longitudinal studies of HIV infection in intravenous drug users: Methodological issues in natural history research.  Hartsock P,  Genser SG editor. National Institute on Drug Abuse Research Monograph Series. 109:Washington, DC: U.S. Government Printing Office; 1991;p. 75–100 DHHS Publication No. ADM 91-1786
  31. Wesson DR. Revival of medical maintenance in the treatment of heroin dependence. JAMA. 1988;259:3314–3315
  32. west AP. Drug abuse treatment as a strategy to prevent human immunodeficiency virus infection among intravenous drug users. Archives of Internal Medicine. 1991;151:1493–1496
  33. Woody GE, McLellan AT, O'Brien CP, Williams J, Navaline H, Dyanick S, et al. HIV sero-conversion and treatment status. In: Problems of drug dependence, 1991.  Harris L editors. National Institute on Drug Abuse Research Monograph Series. 119:Washington, DC: U.S. Government Printing Office; 1992;p. 303; DHHS Publication No. ADM 92-1888

☆ Deborah Rhodes gratefully acknowledges the support of the Robert Wood Johnson Clinical Scholars Program. We thank Annie Umbrich MD, Albert Wu, MD, and Richard Chaisson, MD for their critical review of earlier drafts of the manuscript.

PII: S0740-5472(97)00117-7

Journal of Substance Abuse Treatment
Volume 14, Issue 6 , Pages 535-542 , November 1997

Article Tools